Skip to main content
. Author manuscript; available in PMC: 2019 Jun 20.
Published in final edited form as: SLAS Discov. 2018 Jul 11;23(10):1060–1069. doi: 10.1177/2472555218786509

Figure 4. Validation of FP-based glucagon assay using known IDE inhibitors.

Figure 4

Dose-response curves (A, B) and kinetic analyses (C, D) conducted in the absence or presence of two well-characterized IDE inhibitors: P12–3A (A, C) and ML345 (B, D). For dose-response curves, data are mean ± SEM for each of 3 independent experiments conducted on separate days. For kinetic experiments, data are expressed as double-reciprocal plots; for clarity, we show a single linear regression curve is drawn from the mean ± SEM of 3 independent experiments. Kinetic parameters derived from these results are provided in Table 3.